By Duke Medicine News and Communications
The American Heart Association (AHA) has named Victor J. Dzau, M.D.,
Chancellor for Health Affairs at Duke University and President and CEO
of the Duke University Health System, as one of its Distinguished
Scientists for 2004.
The AHA's annual scientific sessions run from Nov. 7-11.
Dzau,
known for his research into the molecular and genetic mechanisms of
cardiovascular disease, joins nine other prominent medical
investigators as new Distinguished Scientists who will help advize and
guide AHA activities.
The Distinguished Scientist title
"recognizes seminal research work that has importantly advanced our
understanding and management of cardiovascular disease or stroke,"
said. Alice Jacobs, M.D., AHA president. "The criteria used by the
selection committee in making this decision were the novelty,
significance and impact of your research, as well as your stature in
the field."
The AHA created the Distinguished Scientist program
in 2003. Members play an active role in the AHA's early career
development programs, presentations at AHA conferences, and serve as
expert consultants in AHA matters.
Dzau, who came to Duke in
July, 2004, specializes in cardiovascular translational research. His
research has focused on the molecular and genetic mechanisms of
cardiovascular disease and applied genomic and gene transfer
technologies to develop novel approaches to treating disease. He also
has a keen interest in global inequities in health care.
He is
also a member of the Institute of Medicine, the U.S. National Academy
of Science, the Academia Sinica of China and the European Academy of
Science and Arts. He has been named an Honorary Fellow of the Royal
Society of Medicine in Great Britain, and has served as an advisor to
the governments of Canada, South Africa and Taiwan on biomedical and
healthcare programs.
Dzau recently was awarded the Max Delbruck Medal for 2004 by the Max Delbruck Center for Molecular Medicine, Berlin, Germany.
Duke
and Howard Hughes Medical Institute researcher Robert Lefkowitz, M.D.,
was a founding member of the Distinguished Scientist program.